Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Medicinova Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Medicinova Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Nagao Hideki | Director | 0 | Jun 25, 2026 | 1 |
| Beaver Carolyn | Director | – | Jun 25, 2026 | 1 |
| Lemerond Nicole | Director | – | Jun 25, 2026 | 1 |
| Iwaki Yuichi | President and CEO | 966,933 | Jan 20, 2026 | 1 |
| Matsuda Kazuko | Chief Medical Officer | 322,996 | Jan 20, 2026 | 1 |
| OBrien Geoffrey | Vice President | – | Jan 11, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 (view filing) | Nov 28 | 2 days | Nagao HidekiDirector | SSale | −6.75K | $2.25 | −$15.2K | −100.0%0 after | |
| Nov 23, 2022 (view filing) | Nov 21-22 | 2 days | Nagao HidekiDirector | SSale | −5.58K | $2.18 | −$12.2K | −45.3%6.75K after | 2 lots |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Nagao HidekiDirector | SSale | −309 | $2.18 | −$673.62 | −2.4%12.3K after |